首页 | 本学科首页   官方微博 | 高级检索  
     

抗心律失常药物作用的新靶点M3R/IKM3
引用本文:刘艳,许超千,焦军东,王慧珍,董德利,杨宝峰. 抗心律失常药物作用的新靶点M3R/IKM3[J]. 药学学报, 2005, 40(1): 8-8
作者姓名:刘艳  许超千  焦军东  王慧珍  董德利  杨宝峰
作者单位:哈尔滨医科大学 药理教研室, 黑龙江省生物医药重点实验室-省部共建国家重点实验室培育基地, 黑龙江 哈尔滨 150086
摘    要:目的研究心脏M3受体/M3受体介导的钾通道与心律失常的关系,寻找抗心律失常药物的新靶点。方法 分别以结扎大鼠左冠状动脉前降支所致急性心律失常模型和膜片钳技术为基础,观察M3受体的干预作用及作用机制。结果M3受体阻断剂4DAMP(4-diphenylacetoxy-n-methylpiperidine-methiodide)加重结扎大鼠冠状动脉前降支所致心律失常,而M3受体激动剂胆碱能明显对抗其作用。其他亚型受体阻断剂,M1受体阻断剂(prienzepine)、M2受体阻断剂(methotramine)和M4受体阻断剂(tropicamide)对结扎大鼠左冠状动脉前降支所致急性心律失常无影响。在膜片钳实验中发现,胆碱可激活一种延迟整流钾电流(IKM3),此电流可被M3受体阻断剂4DAMP明显抑制。而M1,M2和M4受体阻断剂对胆碱介导的电流无作用。结论胆碱通过激动心肌M3受体诱发一外向钾电流(IKM3),并在维持心脏离子通道平衡中起重要作用。M3受体/IKM3可能是抗心律失常新靶点。

关 键 词:心肌缺血  心律失常  M3受体  延迟整流电流
收稿时间:2004-01-22

M3-R/IKM3a new target of antiarrhythmic agents
LIU Yan,XU Chao-qian,JIAO Jun-dong,WANG Hui-zhen,DONG De-li,YANG Bao-feng. M3-R/IKM3a new target of antiarrhythmic agents[J]. Acta pharmaceutica Sinica, 2005, 40(1): 8-8
Authors:LIU Yan  XU Chao-qian  JIAO Jun-dong  WANG Hui-zhen  DONG De-li  YANG Bao-feng
Abstract:AimTo investigate the relationship between M3-R/IKM3 and arrhythmia in order to find a new target for antiarrhythmic agents. MethodsUsing the acute ischemic model of rats and patch-clamp techniques, the effects of the M3 receptor on the occurrence of arrhythmias and its possible mechanisms were studied. ResultsIn acute ischemic model of rats, the M3 receptor antagonist 4-diphenylacetoxy-n-methylpiperidine-methiodide (4DAMP) increased the occurrence of arrhythmias, and the M3 receptor agonist choline suppressed the onset and the development of arrhythmias (P<0.01). No change was observed after treatment with other receptor antagonists (M1, M2, and M4). With patch-clamp techniques, it was found that choline induced K+ current could be inhibited by 4DAMP. Antagonists toward M1, M2,and M4 receptors all failed to alter the current. ConclusionCholine modulates the cellular electrical properties of the heart, probably by activating a K+ current via stimulation of the M3 receptor. M3-R/IKM3 may act as a new target for antiarrhythmic agents.
Keywords:arrhythmias  M3 receptor  delayed rectifier current  cardiac ischemia
点击此处可从《药学学报》浏览原始摘要信息
点击此处可从《药学学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号